Dr Christine Lee discusses her work on how to capture the patient’s voice by using multiple data sources, such as unstructured FDA archival data and social media.
Study showed an association between early-onset Alzheimer disease and higher levels of low-density lipoprotein cholesterol independent of the effects of APOE, as well as demonstrated enrichment of rare coding variants of APOB.
Considering more individuals are eligible for statin therapy based on 2018 cholesterol guidelines, it is important to examine the possibility that the medication may impair gonadal steroidogenesis.
Increasing the length of nightly sleep may help reduce the risk for cardiovascular disease and metabolic disorders.
PCSK9 inhibition with evolocumab was safe and more effective than statin monotherapy in reducing LDL-C in stable individuals with moderate CKD and clinically evident atherosclerosis.
Persistently high fat mass during adolescence is associated with greater arterial stiffness.
Boehringer Ingelheim and Lilly announced full data from the CAROLINA trial demonstrating that linagliptin, a DPP-4 inhibitor, did not increase CV risk.
Variability in sleep duration and timing is associated with higher odds of metabolic syndrome.
Lowering serum cholesterol levels in patients with type 2 diabetes is associated with diabetic polyneuropathy.
Blood donor screening may serve as a novel strategy for the early diagnosis of familial hypercholesterolemia.
Fasting before a cholesterol test is not necessary when evaluating risk for cardiovascular events.
Want to read more?
Please login or register first to view this content.
Next post in Dyslipidemia